e-Drug3D

158

ACETYLDIGITOXIN

DISCONTINUED


INN
ACETYLDIGITOXIN

cas 1111-39-3
CLASS

CARDIOVASCULAR
CARDIOTONIC

ROUTE (list)

ORAL

ATC code

C01AA01

PK parameters

Target

TARGET NA-K ATPASE

DrugCentral

Sodium,potassium-transporting ATPase UNIPROT P05023 ATP1A1

Download SDF file [(2R,3R,4S,6S)-3-hydroxy-6-[(2R,4S,6S)-4-hydroxy-6-[(2R,3S,4S,6R)-4-hydroxy-6-[[(5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-2-methyloxan-3-yl]oxy-2-methyloxan-3-yl]oxy-2-methyloxan-4-yl] acetate

Formula:
C43H66O14

Calculated chemical properties:

MW 806.96
NB_atoms 57
XLogP 3.82
PSA 181.032
NB_HD 4
NB_HA 14
fsp3 0.91
Lipinski(0=no;1=yes) 0

FDA
NDA 009436 (pdf not found) INN (ACETYLDIGITOXIN) ACYLANID (NOVARTIS) APPROVAL= AP YEAR= 1975 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL